Development of a Core Outcomes Set for Clinical Trials in Inflammatory Bowel Disease: An International Collaboration
Development of a Core Outcomes Set for Clinical Trials in Inflammatory Bowel Disease: An International Collaboration
批准号:
363813
负责人:
Ma Christopher
金额:
$4.01万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-11-01 至 2018-11-01
中文摘要
炎症性肠病(IBD)影响着23.3万加拿大人。IBD是一种无法治愈的终生疾病:患者出现虚弱的肠道症状,生活质量下降,工作能力受损。30%的患者对目前的药物没有反应
英文摘要
Inflammatory bowel disease (IBD) affects 233,000 Canadians. IBD is a lifelong disease without a cure: patients suffer debilitating bowel symptoms, reduced quality of life, and impaired work capacity. 30% of patients do not respond to current medications b
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PATHFINDER: A Pragmatic, Active Comparator, Parallel-Group, Randomized Trial to Evaluate the Optimal First-Line Treatment Strategy for Moderate to Severely Active Ileal Crohn's Disease
-
批准号:469579
-
项目类别:Operating Grants
-
资助金额:$17.83万
-
财政年份:2022
-
负责人:Ma Christopher
-
依托单位:
Hospitalization for Inflammatory Bowel Diseases: Risk Factors, Temporal Trends, and Health Care Utilization
-
批准号:182305
-
项目类别:Summer Student Programs
-
资助金额:$0.22万
-
财政年份:2009
-
负责人:Ma Christopher
-
依托单位: